What COVID-19 seroprevalence surveys can tell us

i

What COVID-19 seroprevalence surveys can tell us

Supporting Files Public Domain

July 8, 2020
By National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

File Language:

English

What COVID-19 seroprevalence surveys can tell us

Details

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
Description:

Serology, or antibody, testing checks a sample of a person’s blood to look for antibodies against SARS-CoV-2, the virus that causes COVID-19. Antibodies usually become detectable in the blood 1-3 weeks after someone is infected.

infographic-what-serology-tells-us.png
Subjects:

Betacoronavirus Clinical Laboratory Techniques Coronavirus Infections/diagnosis COVID-19 Neutralization Tests Pandemics Pneumonia, Viral/diagnosis Prevalence Seroepidemiologic Studies
Document Type:

Poster
Genre:

Infographic
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

urn:sha256:fd3dcae9a3e31b0db74d87b93ef658961fe849c10cd52a99dba4990454b3ae88
Download URL:

https://stacks.cdc.gov/view/cdc/90301/cdc_90301_DS1.png
File Type:

[PNG - 131.46 KB ]

seroprevalance-surveys-tell-us.html

html

File Language:

English

ON THIS PAGE

Details Supporting Files

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.